Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
Open Access
- 23 April 2018
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-14
Abstract
Immune checkpoint inhibitors have not been effective for immunologically “cold” tumors, such as prostate cancer, which contain scarce tumor infiltrating lymphocytes. We hypothesized that select tissue-specific and immunostimulatory bacteria can potentiate these immunotherapies. Here we show that a patient-derived prostate-specific microbe, CP1, in combination with anti-PD-1 immunotherapy, increases survival and decreases tumor burden in orthotopic MYC- and PTEN-mutant prostate cancer models. CP1 administered intra-urethrally specifically homes to and colonizes tumors without causing any systemic toxicities. CP1 increases immunogenic cell death of cancer cells, T cell cytotoxicity, and tumor infiltration by activated CD8 T cells, Th17 T cells, mature dendritic cells, M1 macrophages, and NK cells. CP1 also decreases intra-tumoral regulatory T cells and VEGF. Mechanistically, blocking CP1-recruited T cells from infiltrating the tumor inhibits its therapeutic efficacy. CP1 is an immunotherapeutic tool demonstrating how a tissue-specific microbe can increase tumor immunogenicity and sensitize an otherwise resistant cancer type to immunotherapy.Keywords
This publication has 69 references indexed in Scilit:
- Genetic markers associated with early cancer‐specific mortality following prostatectomyCancer, 2013
- Th1-Th17 Cells Contribute to the Development of Uropathogenic Escherichia coli-Induced Chronic Pelvic PainPLOS ONE, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Preclinical Mouse Models of Human Prostate Cancer and Their Utility in Drug DiscoveryCurrent Protocols in Pharmacology, 2010
- Human prostate‐infiltrating CD8+ T lymphocytes are oligoclonal and PD‐1+The Prostate, 2009
- Urothelial Cultures Support Intracellular Bacterial Community Formation by UropathogenicEscherichia coliInfection and Immunity, 2009
- CD40 Ligand‐activated, antigen‐specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I‐ and class II‐binding peptidesImmunology, 2008
- Sex and virulence in Escherichia coli: an evolutionary perspectiveMolecular Microbiology, 2006
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- The Complete Genome Sequence of Escherichia coli K-12Science, 1997